Haverford Trust Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9M | Buy |
387,129
+84,941
| +28% | +$2.26M | 0.1% | 98 |
|
|
2025
Q4 | $7.52M | Sell |
302,188
-80,386
| -21% | -$2.03M | 0.07% | 108 |
|
|
2025
Q3 | $9.75M | Sell |
382,574
-28,547
| -7% | -$705K | 0.09% | 103 |
|
|
2025
Q2 | $9.97M | Sell |
411,121
-29,754
| -7% | -$694K | 0.09% | 101 |
|
|
2025
Q1 | $11.2M | Buy |
440,875
+80,495
| +22% | +$2.11M | 0.11% | 95 |
|
|
2024
Q4 | $9.56M | Sell |
360,380
-131,837
| -27% | -$3.58M | 0.09% | 100 |
|
|
2024
Q3 | $14.2M | Sell |
492,217
-12,901
| -3% | -$376K | 0.14% | 89 |
|
|
2024
Q2 | $14.1M | Buy |
505,118
+842
| +0.2% | +$23.2K | 0.15% | 88 |
|
|
2024
Q1 | $14M | Sell |
504,276
-12,453
| -2% | -$346K | 0.15% | 88 |
|
|
2023
Q4 | $14.9M | Buy |
516,729
+14,003
| +3% | +$423K | 0.17% | 81 |
|
|
2023
Q3 | $16.7M | Sell |
502,726
-19,933
| -4% | -$705K | 0.2% | 71 |
|
|
2023
Q2 | $19.2M | Sell |
522,659
-13,643
| -3% | -$531K | 0.22% | 71 |
|
|
2023
Q1 | $21.9M | Buy |
536,302
+3,830
| +0.7% | +$165K | 0.26% | 66 |
|
|
2022
Q4 | $27.3M | Buy |
532,472
+207
| +0% | +$9.92K | 0.34% | 61 |
|
|
2022
Q3 | $23.3M | Buy |
532,265
+10,977
| +2% | +$533K | 0.32% | 60 |
|
|
2022
Q2 | $27.3M | Sell |
521,288
-40,685
| -7% | -$2.07M | 0.36% | 60 |
|
|
2022
Q1 | $29.1M | Buy |
561,973
+17,922
| +3% | +$930K | 0.34% | 63 |
|
|
2021
Q4 | $32.1M | Sell |
544,051
-659
| -0.1% | -$32.7K | 0.35% | 60 |
|
|
2021
Q3 | $23.4M | Buy |
544,710
+6,167
| +1% | +$273K | 0.28% | 64 |
|
|
2021
Q2 | $21.1M | Buy |
538,543
+60,714
| +13% | +$2.36M | 0.25% | 66 |
|
|
2021
Q1 | $17.3M | Buy |
477,829
+4,246
| +0.9% | +$151K | 0.22% | 67 |
|
|
2020
Q4 | $17.4M | Sell |
473,583
-21,193
| -4% | -$777K | 0.25% | 59 |
|
|
2020
Q3 | $17.2M | Buy |
494,776
+76
| +0% | +$2.67K | 0.27% | 59 |
|
|
2020
Q2 | $15.3M | Sell |
494,700
-11,404
| -2% | -$387K | 0.26% | 60 |
|
|
2020
Q1 | $15.7M | Buy |
506,104
+31,659
| +7% | +$1.08M | 0.32% | 59 |
|
|
2019
Q4 | $17.6M | Buy |
474,445
+906
| +0.2% | +$32.3K | 0.29% | 65 |
|
|
2019
Q3 | $16.1M | Sell |
473,539
-9,463
| -2% | -$344K | 0.28% | 67 |
|
|
2019
Q2 | $19.9M | Buy |
483,002
+3,291
| +0.7% | +$131K | 0.36% | 62 |
|
|
2019
Q1 | $19.3M | Sell |
479,711
-9,721
| -2% | -$389K | 0.36% | 63 |
|
|
2018
Q4 | $20.3M | Sell |
489,432
-20,010
| -4% | -$831K | 0.43% | 57 |
|
|
2018
Q3 | $21.3M | Sell |
509,442
-6,012
| -1% | -$231K | 0.39% | 60 |
|
|
2018
Q2 | $17.7M | Sell |
515,454
-244,904
| -32% | -$8.37M | 0.35% | 64 |
|
|
2018
Q1 | $25.6M | Sell |
760,358
-369,156
| -33% | -$12.7M | 0.51% | 54 |
|
|
2017
Q4 | $38.8M | Sell |
1,129,514
-4,964
| -0.4% | -$169K | 0.76% | 45 |
|
|
2017
Q3 | $38.4M | Buy |
1,134,478
+28,332
| +3% | +$911K | 0.8% | 43 |
|
|
2017
Q2 | $35.3M | Buy |
1,106,146
+35,937
| +3% | +$1.13M | 0.77% | 47 |
|
|
2017
Q1 | $34.7M | Buy |
1,070,209
+47,836
| +5% | +$1.51M | 0.79% | 46 |
|
|
2016
Q4 | $31.5M | Buy |
1,022,373
+10,805
| +1% | +$330K | 0.76% | 47 |
|
|
2016
Q3 | $32.5M | Buy |
1,011,568
+23,267
| +2% | +$778K | 0.81% | 46 |
|
|
2016
Q2 | $33M | Buy |
988,301
+32,737
| +3% | +$1.04M | 0.83% | 48 |
|
|
2016
Q1 | $26.9M | Buy |
955,564
+702,638
| +278% | +$20.1M | 0.7% | 52 |
|
|
2015
Q4 | $7.75M | Buy |
252,926
+8,506
| +3% | +$268K | 0.21% | 66 |
|
|
2015
Q3 | $7.28M | Buy |
244,420
+26,265
| +12% | +$842K | 0.21% | 61 |
|
|
2015
Q2 | $6.94M | Buy |
218,155
+11,447
| +6% | +$373K | 0.19% | 64 |
|
|
2015
Q1 | $6.82M | Buy |
206,708
+3,477
| +2% | +$111K | 0.19% | 68 |
|
|
2014
Q4 | $6.01M | Sell |
203,231
-612
| -0.3% | -$17.5K | 0.17% | 73 |
|
|
2014
Q3 | $5.72M | Sell |
203,843
-14,459
| -7% | -$406K | 0.17% | 72 |
|
|
2014
Q2 | $6.15M | Buy |
218,302
+166
| +0.1% | +$4.73K | 0.18% | 71 |
|
|
2014
Q1 | $6.65M | Sell |
218,136
-130,500
| -37% | -$3.89M | 0.21% | 68 |
|
|
2013
Q4 | $10.1M | Buy |
348,636
+20,513
| +6% | +$597K | 0.28% | 65 |
|
|
2013
Q3 | $8.94M | Sell |
328,123
-917
| -0.3% | -$24.9K | 0.33% | 53 |
|
|
2013
Q2 | $8.74M | Buy |
+329,040
| New | +$9.09M | 0.29% | 64 |
|
Other funds holding PFE
VCM
VPM
Haverford Trust Company's PFE Position: Q1 2026 in Review
Haverford Trust Company increased its Pfizer (PFE) stake by 28% in Q1 2026, buying an estimated $2.26M and bringing the position to 387,129 shares worth $10.9M. The position accounts for 0.1% of the portfolio, ranked #98.
Haverford Trust Company first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.8M in Q4 2017. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Haverford Trust Company held 387,129 shares of Pfizer worth $10.9M as of Q1 2026.
- Haverford Trust Company bought 84,941 Pfizer shares in Q1 2026, an estimated $2.26M.
- Pfizer made up 0.1% of Haverford Trust Company's portfolio in Q1 2026, its #98 holding.
- Haverford Trust Company first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Haverford Trust Company's Pfizer position peaked at $38.8M in Q4 2017.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Haverford Trust Company's 13F filing for Q1 2026, filed 11 May 2026.